Peptic Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update

Peptic ulcers are open sores that develop on the inside lining of the esophagus, stomach, and the upper portion of the small intestine. Symptoms include nausea or vomiting, unexplained weight loss, appetite changes, and abdominal pain. Risk factors include smoking and alcoholism. It can be treated via antibiotics, acid blockers, antacids, and proton pump inhibitors.

The Peptic ulcers drugs in development market research report provides comprehensive information on the therapeutics under development for peptic ulcers, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for peptic ulcers and features dormant and discontinued projects.

What are the key targets in the peptic ulcers pipeline products market?

The key targets in the peptic ulcers pipeline products market are potassium transporting ATPase alpha chain 1 gastric H (+)/K, prostaglandin G/H synthase 2, cholinergic receptor muscarinic, epidermal growth factor receptor, histamine H2 receptor, and prostaglandin G/H synthase 1.

Peptic Ulcers Pipeline Products Analysis Market by Targets

For more target insights, download a free report sample

What are the key mechanisms of action in the peptic ulcers pipeline products market?

The key mechanisms of action in the peptic ulcers pipeline products market are potassium transporting ATPase alpha chain 1 gastric H (+)/K inhibitor, prostaglandin G/H synthase 2 inhibitor, cholinergic receptor muscarinic antagonist, epidermal growth factor receptor agonist, histamine H2 receptor antagonist, and prostaglandin G/H synthase 1 inhibitor.

Peptic Ulcers Pipeline Products Market Analysis by Mechanism of Actions

For more mechanism of actions insights, download a free report sample

What are the key routes of administration in the peptic ulcers pipeline products market?

The key routes of administration in the peptic ulcers pipeline products market are oral, intravenous, parenteral, and intravenous drip.

Peptic Ulcers Pipeline Products Market Analysis by Routes of Administration

For more routes of administration insights, download a free report sample

What are the different molecule types in the peptic ulcers pipeline products market?

The different molecule types in the peptic ulcers pipeline products market are small molecule and fusion protein.

Peptic Ulcers Pipeline Products Market Analysis by Molecule Type

To know more about molecule types, download a free report sample

Which are the major companies in the peptic ulcers pipeline products market?

Some of the major companies in the peptic ulcers pipeline products market are Jiangsu Carephar Pharmaceutical Co Ltd, XuanZhu Biological Technology Co Ltd, Hunan Mingrui Pharmaceutical Co Ltd, Ilyang Pharmaceutical Co Ltd, Addpharma Inc, Axsome Therapeutics Inc, CalyGene Biotechnology Inc, Cinclus Pharma AG, Daewoong Pharmaceutical Co Ltd, and Edenbridge Pharmaceuticals LLC.

Peptic ulcers Pipeline Products Market Analysis by Companies

To know more about major companies, download a free report sample

Market Report Scope

Scope

• The report provides a snapshot of the global therapeutic landscape of peptic ulcers
• The report reviews pipeline therapeutics for peptic ulcers by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in peptic ulcers therapeutics and enlists all their major and minor projects
• The report assesses peptic ulcers therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA), and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews the latest news related to pipeline therapeutics for peptic ulcers

Reasons to Buy

• Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
• Identify emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
• Identify and understand important and diverse types of therapeutics under development for peptic ulcers
• Identify potential new clients or partners in the target demographic
• Develop strategic initiatives by understanding the focus areas of leading companies
• Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics
• Devise corrective measures for pipeline projects by understanding peptic ulcers pipeline depth and focus on Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from the pipeline